Literature DB >> 6604068

Chronic granulomatous disease of childhood: a changing pattern?

H H Frayha, W D Biggar.   

Abstract

We have followed nine male patients with Chronic Granulomatous Disease at The Hospital for Sick Children, Toronto, since 1972. The diagnosis was established in each case by the failure of neutrophils to reduce nitroblue tetrazolium dye and to kill Staphylococcus aureus normally in vitro. Bacterial infections began between 6 months and 14 years of age. In five of the nine patients, infections began after 4 years of age. The first significant infection in five patients was a liver abscess(es), and one patient each had lymphadenitis, pulmonary aspergillosis, a parapharyngeal abscess, and a draining inguinal incision following surgery. Following diagnosis, all patients were started on Trimethoprim-Sulfamethoxazole at a dose of 2 mg/kg/day of Trimethoprim. The patients have been followed for 50 patient-years. Five of nine patients have been free of infection during 16 years of observation. For the remaining four patients, there have been six infections during 34 years of observation. A possible infection-related death occurred in one patient. The patients reported here appear to differ from those in previous reports. They present later in life, often with a liver abscess. They have a low incidence of subsequent bacterial infections which may, in part, be due to Trimethoprim-Sulfamethoxazole prophylaxis. The patients with chronic granulomatous disease reported here appear to have a better prognosis than previously thought.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604068     DOI: 10.1007/bf00915354

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

1.  THIRTEEN BOYS WITH PROGRESSIVE SEPTIC GRANULOMATOSIS.

Authors:  M J CARSON; D L CHADWICK; C A BRUBAKER; R S CLELAND; B H LANDING
Journal:  Pediatrics       Date:  1965-03       Impact factor: 7.124

2.  A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome.

Authors:  R A BRIDGES; H BERENDES; R A GOOD
Journal:  AMA J Dis Child       Date:  1959-04

Review 3.  Chronic granulomatous disease.

Authors:  R B Johnston; S L Newman
Journal:  Pediatr Clin North Am       Date:  1977-05       Impact factor: 3.278

4.  Chronic granulomatous disease of childhood with onset of symptoms at age 11 years.

Authors:  D Y Sanders; M R Cooper; C E McCall; L R DeChatelet
Journal:  J Pediatr       Date:  1972-01       Impact factor: 4.406

5.  Chronic granulomatous disease of childhood in a 23-year-old man.

Authors:  H H Balfour; J J Shehan; C E Speicher; E Kauder
Journal:  JAMA       Date:  1971-08-16       Impact factor: 56.272

6.  Roentgenologic manifestations in children with a genetic defect of polymorphonuclear leukocyte function. Chronic granulomatous disease of childhood.

Authors:  J J Wolfson; P G Quie; S D Laxdal; R A Good
Journal:  Radiology       Date:  1968-07       Impact factor: 11.105

7.  Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function.

Authors:  R A Good; P G Quie; D B Windhorst; A R Page; G E Rodey; J White; J J Wolfson; B H Holmes
Journal:  Semin Hematol       Date:  1968-07       Impact factor: 3.851

8.  Nitroblue-tetrazolium test in children with fatal granulomatous disease and newborn infants.

Authors:  B H Park; B M Holmes; G E Rodey; R A Good
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

9.  Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP).

Authors:  Y Kobayashi; D Amano; K Ueda; Y Kagosaki; T Usui
Journal:  Eur J Pediatr       Date:  1978-04-20       Impact factor: 3.183

10.  Chronic granulomatous disease: mode of action of sulfamethoxazole/trimethoprim.

Authors:  F K Gmünder; R A Seger
Journal:  Pediatr Res       Date:  1981-12       Impact factor: 3.756

View more
  2 in total

1.  Chronic granulomatous disease of childhood: gastric manifestation and response to salazosulfapyridine therapy.

Authors:  J Stopyrowa; K Fyderek; B Sikorska; D Kowalczyk; M Zembala
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

2.  Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease.

Authors:  S Kloss; A Schuster; H Schroten; J Lamprecht; V Wahn
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.